THE PROGNOSTIC ROLE OF WHOLE BLOOD VISCOSITY AND BONE MARROW FIBROSIS IN PREDICTING SURVIVAL OUTCOMES IN NEW DIAGNOSIS MULTIPLE MYELOMA PATIENTS

THE PROGNOSTIC ROLE OF WHOLE BLOOD VISCOSITY AND BONE MARROW FIBROSIS IN PREDICTING SURVIVAL OUTCOMES IN NEW DIAGNOSIS MULTIPLE MYELOMA PATIENTS

Objective: This study aimed to evaluate the prognostic role of whole blood viscosity and bone marrow fibrosis in predicting survival outcomes and relationships with prognostic predictors, such as international scorin system albumin levels, beta2-microglobulin, total protein, albumin and lactate dehy...

Full description

Saved in:

Bibliographic Details
Main Author:	Mustafa Duran
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137924028542
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Identification of an Autophagy-Related Signature Based on Whole Bone Marrow Sequencing for the Prognosis and Immune Microenvironment Characterization of Multiple Myeloma
by: Licheng Li, et al.
Published: (2022-01-01)

Bone marrow fibrosis – the basis of mielofibrosis: pathogenesis, prognostication and antifibrogenic targeted strategies.
by: A. S. Timchenko, et al.
Published: (2018-04-01)

Bone Marrow Neutrophils of Multiple Myeloma Patients Exhibit Myeloid-Derived Suppressor Cell Activity
by: Julia Petersson, et al.
Published: (2021-01-01)

Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis
by: Samuel Urrutia, et al.
Published: (2024-11-01)

Diagnosis and Treatment of Bone Disease in Multiple Myeloma: Spotlight on Spinal Involvement
by: Patrizia Tosi
Published: (2013-01-01)

The Evolution of Prognostic Factors in Multiple Myeloma
by: Amr Hanbali, et al.
Published: (2017-01-01)

Prognostic Value of PSMB5 and Correlations with LC3II and Reactive Oxygen Species Levels in the Bone Marrow Mononuclear Cells of Bortezomib-Resistant Multiple Myeloma Patients
by: Eva Plakoula, et al.
Published: (2025-01-01)

The correlation between serum bone metabolism indexes and bone disease and survival in newly diagnosed multiple myeloma patients
by: Linlin Huang, et al.
Published: (2024-12-01)

Megakaryocyte contribution to bone marrow fibrosis: many arrows in the quiver
by: Alessandro Malara, et al.
Published: (2018-11-01)

A study on the measurement of the reference range of the whole blood viscosity in Thoroughbred horses
by: Y Ha, et al.
Published: (2024-11-01)

A study on the measurement of the reference range of the whole blood viscosity in Thoroughbred horses
by: Y Ha, et al.
Published: (2024-11-01)

3 years survival of patients with multiple myeloma.
by: Julio Dámaso Fernández Águila, et al.
Published: (2006-12-01)

THE UTILITY OF BLOOD AND BONE MARROW FILMS AND TREPHINE BIOPSY SECTIONS IN THE DIAGNOSIS OF PARASITIC INFECTIONS
by: Clare Miller, et al.
Published: (2015-05-01)

Prognostic correlation analysis of multiple myeloma based on HALP score of peripheral blood before chemotherapy
by: CHEN Min, et al.
Published: (2025-01-01)

Whole genome sequencing and the genetics of extramedullary disease in multiple myeloma
by: Nicholas Bingham, et al.
Published: (2025-01-01)

Peripheral blood smear – An expeditious test in the preliminary diagnosis of bone marrow embolism in a case of multiple fractures: A case report
by: Rajalakshmi B. Rajashekar, et al.
Published: (2024-04-01)

Cellular Mechanisms of Multiple Myeloma Bone Disease
by: Angela Oranger, et al.
Published: (2013-01-01)

Elevated whole blood viscosity is associated with an impaired insulin-stimulated myocardial glucose metabolism
by: Elena Succurro, et al.
Published: (2024-12-01)

Bone marrow transplantation: nursing diagnosis in receivers
by: Vinicius Lino de Souza Neto, Michel Siqueira da Silva, Ádima KelleVeras de Lima, Altamiro Lucas Pamplona Fernandes Gurgel, Ana Elza Oliveira de Mendonça, Cristiane da Silva Costa
Published: (2020-10-01)

5‐Hydroxymethylcytosine Profiles of cfDNA in Urine as Diagnostic, Differential Diagnosis and Prognostic Markers for Multiple Myeloma
by: Weiwei Xie, et al.
Published: (2024-12-01)

Tunneling nanotubes between bone marrow stromal cells support transmitophagy and resistance to apoptosis in myeloma
by: Antonio Giovanni Solimando, et al.
Published: (2025-01-01)

SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE
by: Stergios Intzes, et al.
Published: (2021-01-01)

Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis
by: Fabiana Gentilini, et al.
Published: (2012-01-01)

Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis
by: Fabiana Gentilini, et al.
Published: (2012-05-01)

Could kDNA-PCR in Peripheral Blood Replace the Examination of Bone Marrow for the Diagnosis of Visceral Leishmaniasis?
by: Natalia Souza de Godoy, et al.
Published: (2016-01-01)

The characteristics of patients with multiple myeloma surviving over 10 years
by: Beihui Huang, et al.
Published: (2024-11-01)

Optimizing treatment sequencing in multiple myeloma: a novel model to predict survival outcomes
by: Maria Teresa Petrucci, et al.
Published: (2024-12-01)

The Role of Bone Marrow Cells and Peripheral Blood Cells in the Osteogenic Process
by: Vukelić-Nikolić Marija Đ., et al.
Published: (2024-12-01)

Association between clinical outcomes, peripheral blood and cytomorphologic features of bone marrow in visceral leishmaniasis
by: Maria Aline Ferreira De Cerqueira, et al.
Published: (2024-12-01)

Whole lot of blood: does more equal better for survival?
by: Sophia Smith, et al.
Published: (2024-11-01)

Prolonged Myelosuppression due to Progressive Bone Marrow Fibrosis in a Patient with Acute Promyelocytic Leukemia
by: Yuta Inagawa, et al.
Published: (2019-01-01)

Bone-independent extramedullary disease is associated with inferior overall survival in multiple myeloma patients: a single center, real-world experience
by: Ke Xu, et al.
Published: (2024-12-01)

Toll-like receptor 1/2 activation reduces immunoglobulin free light chain production by multiple myeloma cells in the context of bone marrow stromal cells and fibronectin.
by: Jahan Abdi, et al.
Published: (2025-01-01)

Bone Marrow Stem Cell Population in Single- and Multiple-Level Aspiration
by: Xiangguo Che, et al.
Published: (2024-11-01)

Construction and validation of a prognostic model of angiogenesis-related genes in multiple myeloma
by: Rui Hu, et al.
Published: (2024-10-01)

Concordance of Peripheral Blood and Bone Marrow Next-Generation Sequencing in Hematologic Neoplasms
by: Chayanit Jumniensuk, et al.
Published: (2022-01-01)

Clinical, Histological, and Scintigraphic Comparative Study of the Use of Mandibular Bone Marrow and Peripheral Blood in Bone Neoformation
by: Paulo José Pasquali, et al.
Published: (2021-01-01)

Blood Cancer and the Heart: Light Chain Cardiomyopathy in Refractory Multiple Myeloma
by: Abdulbaril Olagunju, et al.
Published: (2022-01-01)

Construction and validation of an 18F-FDG-PET/CT-based prognostic model to predict progression-free survival in newly diagnosed multiple myeloma patients
by: Xiaoqing Dong, et al.
Published: (2024-12-01)

Real-world prognostic factors in autotransplanted multiple myeloma patients with severe renal impairment: study of the Polish Myeloma Study Group
by: Anna Waszczuk-Gajda, et al.
Published: (2020-04-01)